Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 101–200 of 1,000
Wang, S., Garcia, A. J., Wu, M., Lawson, D. A., Witte, O. N., & Wu, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510652103 · Cited by 308
Pushing the limits of targeted therapy in chronic myeloid leukaemia
O'Hare, T., Zabriskie, M. S., Eiring, A. M., & Deininger, M. W. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3317 · Cited by 304
Janssen, K., Alberici, P., Fsihi, H., Gaspar, C., Breukel, C., Franken, P., Rosty, C., Abal, M., El Marjou, F., Smits, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.011 · Cited by 298
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Koptyra, M., Falinski, R., Nowicki, M. O., Stoklosa, T., Majsterek, I., Nieborowska-Skorska, M., Blasiak, J., & Skorski, T. (2006) · Blood · doi:10.1182/blood-2005-07-2815 · Cited by 298
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
Majeti, R., Becker, M. W., Tian, Q., Lee, T.-L. M., Yan, X., Liu, R., Chiang, J.-H., Hood, L., Clarke, M. F., & Weissman, I. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900089106 · Cited by 281
“We have also shown that this pathway is aberrantly activated in downstream progenitors in the blast crisis phase of chronic myelogenous leukemia, resulting in the nuclear localization of beta-catenin where it likely acts to stimulate self-renewal and contributes to the formation of leukemia stem cells (29).”
BackgroundHan, Y.-C., Park, C. Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J.-B., Liu, M., Zou, Y., Weissman, I. L., & Gu, H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090831 · Cited by 290
Luckey, C. J., Bhattacharya, D., Goldrath, A. W., Weissman, I. L., Benoist, C., & Mathis, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511137103 · Cited by 290
Therapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I.-I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 286
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
Pellagatti, A., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M. G., Jädersten, M., Killick, S., Verma, A., Norbury, C. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.31 · Cited by 288
Kikushige, Y., Miyamoto, T., Yuda, J., Jabbarzadeh-Tabrizi, S., Shima, T., Takayanagi, S.-I., Niiro, H., Yurino, A., Miyawaki, K., Takenaka, K., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.011 · Cited by 286
“Furthermore, in human CML, accumulation of b-catenin to the nucleus occurs especially in the CD45RACD123 population of GMP-like phenotype that is finally transformed into LSCs at myeloid BC (Jamieson et al., 2004).”
BackgroundDifferential Expression of Novel Potential Regulators in Hematopoietic Stem Cells
Forsberg, E. C., Prohaska, S. S., Katzman, S., Heffner, G. C., Stuart, J. M., & Weissman, I. L. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010028 · Cited by 285
“population of normally non-self-renewing cells [82].”
Jamieson, C. H. M., Gotlib, J., Durocher, J. A., Chao, M. P., Mariappan, M. R., Lay, M., Jones, C., Zehnder, J. L., Lilleberg, S. L., & Weissman, I. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601462103 · Cited by 286
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222861110 · Cited by 277
“Jamieson CH, et al. (2004) Granulocyte-macrophage progenitors as candidate leuke- mic stem cells in blast-crisis CML.”
BackgroundSelf-citationChronic myeloid leukemia, version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Radich, J. P., Deininger, M., Abboud, C. N., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., Curtin, P., DeAngelo, D. J., Gotlib, J., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0071 · Cited by 277
Self-citationCilloni, D., & Saglio, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1613 · Cited by 274
Hehlmann, R. (2012) · Blood · doi:10.1182/blood-2012-03-380147 · Cited by 273
“Genes overexpressed, down regulated or deregulated in BC include SOCS2, CD52, HLA antigens, PRAME, JunB, Fos, FosB, Il8 and genes of the Wnt/ß-catenin pathway.(25)”
BackgroundJi, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., Litchfield, D. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.034 · Cited by 270
“Leukemic stem cells in chronic myelogenous leukemia (CML) have high nuclear b-catenin levels, presumably driven by Bcr-Abl (Jamieson et al., 2004).”
BackgroundHu, Y., Swerdlow, S., Duffy, T. M., Weinmann, R., Lee, F. Y., & Li, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606509103 · Cited by 271
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., & So, C. W. E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 270
“b-Catenin is associated with imatinib resistance in chronic myeloid leukemia (CML) (Jamieson et al., 2004) and has recently been shown to be critical for the establishment of aggressive cutaneous CSCs that express high levels of CD34 (Malanchi et al.”
BackgroundMilojkovic, D., & Apperley, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1068 · Cited by 265
“Amplification of BCR-ABL1 occurs more commonly in advanced-phase disease (71) and was first reported in 3 of 11”
BackgroundZhang, B., Li, M., McDonald, T., Holyoake, T. L., Moon, R. T., Campana, D., Shultz, L., & Bhatia, R. (2013) · Blood · doi:10.1182/blood-2012-02-412890 · Cited by 264
“Enhanced Wnt– b-catenin activity is reported to contribute to LSC transformation in blast crisis CML, although its role in CP CML is less clear.(32,33) In a BCR-ABL transduction-transplantation model, expression of BCRABL in b-catenin–deleted HSCs resulted in reduced LSC self-renewal and leukemia development.”
BackgroundChronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Deininger, M. W., Shah, N. P., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., DeAngelo, D. J., Gotlib, J., Hobbs, G., Maness, L., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0047 · Cited by 262
Zhang, B., Strauss, A. C., Chu, S., Li, M., Ho, Y., Shiang, K.-D., Snyder, D. S., Huettner, C. S., Shultz, L., Holyoake, T., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.011 · Cited by 256
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D'Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253
“High levels of Wnt expression was also observed in granulocyte-macrophage progenitors isolated from chronic myeloid leukemia (CML) patients and correlated with increased self-renewal (Jamieson et al., 2004).”
BackgroundRegulation of hematopoietic and leukemic stem cells by the immune system
Riether, C., Schürch, C. M., & Ochsenbein, A. F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.89 · Cited by 250
“(b) In contrast, in blast crisis CML and AML patients, LSCs exhibited immunophenotypes of LRPs, such as lymphoid-primed MPPs (LMPPs)(31) or GMPs.(30,31) This supports the concept that other more differentiated cells can give rise to LSCs after re-acquisition of self-renewal (progenitor cell-of-origin).”
BackgroundCD44: More than a mere stem cell marker
Morath, I., Hartmann, T. N., & Orian-Rousseau, V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.009 · Cited by 248
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900189106 · Cited by 246
“Quantitative RT-PCR to detect axin2, c-myc, GSK3 transcripts, and the GSK3 isoforms in normal versus CML HSC and progenitors was performed with SYBR Greener two-Step Q-RT-PCR Kit (Invitrogen) (SI Methods) (1).”
BackgroundMethodMazieres, J., He, B., You, L., Xu, Z., & Jablons, D. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.040 · Cited by 244
ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis
Zipeto, M. A., Court, A. C., Sadarangani, A., Delos Santos, N. P., Balaian, L., Chun, H.-J., Pineda, G., Morris, S. R., Mason, C. N., Geron, I., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.004 · Cited by 244
“, 1996) has greatly reduced morbidity and mortality inCPCML, therapeutic resistanceoccurs throughBCR-ABL1mutation and/or amplification that leads to additional genetic and epigeneticmodifications that promote progression (Abrahamsson et al., 2009; Goff et al., 2013; Jamieson et al., 2004; Quintas-Cardama et al., 2014;…”
InfluentialMulti-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Guo, W., Lasky, J. L., Chang, C.-J., Mosessian, S., Lewis, X., Xiao, Y., Yeh, J. E., Chen, J. Y., Iruela-Arispe, M. L., Varella-Garcia, M., et al. (2008) · Nature · doi:10.1038/nature06933 · Cited by 241
Will, B., Zhou, L., Vogler, T. O., Ben-Neriah, S., Schinke, C., Tamari, R., Yu, Y., Bhagat, T. D., Bhattacharyya, S., Barreyro, L., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399683 · Cited by 238
Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
Quintás-Cardama, A., Kantarjian, H. M., & Cortes, J. E. (2009) · Cancer Control · doi:10.1177/107327480901600204 · Cited by 238
Cancer stem cells: A contentious hypothesis now moving forward
O’Connor, M. L., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Wang, Z., Qiao, L., & Duan, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.012 · Cited by 233
PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells
Li, H., Chen, X., Calhoun-Davis, T., Claypool, K., & Tang, D. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5878 · Cited by 230
“In support of the first tenet, both chronic myelogenous leukemia ( 11 ) and acute myelogenous leukemia (12) seem to have arisen from the committed progenitor cells that have acquired self-renewing capabilities.”
BackgroundDrugging Wnt signalling in cancer
Polakis, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.126 · Cited by 228
“Excessive Wnt signalling was apparent in granulocytic-macrophage progenitors isolated from CML patients, and their capacity for proliferation and self-renewal was attenuated by the ectopic expression of the Wnt pathway inhibitor Axin (Jamieson et al, 2004).”
BackgroundRecent advances in cancer stem cells
Cho, R. W., & Clarke, M. F. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.017 · Cited by 227
“b-catenin was shown to be involved in self-renewal of hematopoietic stem cells [51] as well as chronic myeloid leukemic stem cells from blast-crisis specimens [52].”
BackgroundHeidel, F. H., Bullinger, L., Feng, Z., Wang, Z., Neff, T. A., Stein, L., Kalaitzidis, D., Lane, S. W., & Armstrong, S. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.017 · Cited by 225
“One such pathway is the canonical Wnt-pathway (Jamieson et al., 2004; Majeti et al., 2009; Malhotra and Kincade, 2009; Muller-Tidow et al., 2004; Reya et al., 2003; Zhao et al., 2007). β-catenin, the pathway’s central effector molecule, is negatively regulated via phosphorylation by a multiprotein…”
BackgroundIsolation, identification, and characterization of cancer stem cells: A review
Abbaszadegan, M. R., Bagheri, V., Razavi, M. S., Momtazi, A. A., Sahebkar, A., & Gholamin, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25759 · Cited by 225
“Aberrant activation of this self-renewal pathway caused maintenance and propagation of leukemia stem cells (LSCs) in CML and breast CSCs (Jamieson et al., 2004; Korkaya et al., 2009).”
BackgroundHwang-Verslues, W. W., Kuo, W.-H., Chang, P.-H., Pan, C.-C., Wang, H.-H., Tsai, S.-T., Jeng, Y.-M., Shew, J.-Y., Kung, J. T., Chen, C.-H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008377 · Cited by 223
“and different leukemia stem cells can give rise to different types of leukemia”
BackgroundPP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
Neviani, P., Harb, J. G., Oaks, J. J., Santhanam, R., Walker, C. J., Ellis, J. J., Ferenchak, G., Dorrance, A. M., Paisie, C. A., Eiring, A. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68951 · Cited by 221
“The existence of a JAK2–β-catenin pathway requiring BCR-ABL1 expression, but not its activity, does not contradict the BCR-ABL1 kinase–dependent β-catenin induction/stabilization observed in CML progenitors (38, 39).”
BackgroundNatural course and biology of CML
Chereda, B., & Melo, J. V. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2325-z · Cited by 220
Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Sukhdeo, K., Mani, M., Zhang, Y., Dutta, J., Yasui, H., Rooney, M. D., Carrasco, D. E., Zheng, M., He, H., Tai, Y.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610299104 · Cited by 216
Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Coluccia, A. M. L., Vacca, A., Duñach, M., Mologni, L., Redaelli, S., Bustos, V. H., Benati, D., Pinna, L. A., & Gambacorti‐Passerini, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601485 · Cited by 217
“Whereas b-catenin accumulation in BC cells could be accounted for by restored mRNA transcription (Jamieson et al, 2004), we observed that imatinib reduced the active S/T-nonphospho pool of b-catenin, pointing to a Bcr-Abl-mediated b-catenin stabilization and transcriptional activation.”
BackgroundResultInfluentialThe way Wnt works: Components and mechanism
Saito-Diaz, K., Chen, T. W., Wang, X., Thorne, C. A., Wallace, H. A., Page-McCaw, A., & Lee, E. (2013) · Growth Factors · doi:10.3109/08977194.2012.752737 · Cited by 215
“Similarly, elevated Wnt signaling in granulocyte–macrophage progenitor cells obtained from chronic myeloid leukemia patients has enhanced leukemic potential (Jamieson et al. 2004).”
BackgroundMa, Y., Cui, W., Yang, J., Qu, J., Di, C., Amin, H. M., Lai, R., Ritz, J., Krause, D. S., & Chai, L. (2006) · Blood · doi:10.1182/blood-2006-02-001594 · Cited by 215
Chronic Myeloid Leukemia: Diagnosis and Treatment
Quintás-Cardama, A., & Cortes, J. E. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.7.973 · Cited by 215
Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis
Hérault, A., Binnewies, M., Leong, S., Calero-Nieto, F. J., Zhang, S. Y., Kang, Y.-A., Wang, X., Pietras, E. M., Chu, S. H., Barry-Holson, K., et al. (2017) · Nature · doi:10.1038/nature21693 · Cited by 214
Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin
Jeannet, G., Scheller, M., Scarpellino, L., Duboux, S., Gardiol, N., Back, J., Kuttler, F., Malanchi, I., Birchmeier, W., Leutz, A., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102558 · Cited by 215
Mimeault, M., Hauke, R., Mehta, P. P., & Batra, S. K. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00088.x · Cited by 212
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Stewart, J. M., Shaw, P. A., Gedye, C., Bernardini, M. Q., Neel, B. G., & Ailles, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005529108 · Cited by 209
“Moreover, an analogous switch in CSC phenotype is believed to occur during conversion from the chronic phase of chronic myeloid leukemia, in which CSCs reside within the hematopoietic stem cell compartment, to myeloid blast crisis where CSCs arise from granulocyte/macrophage progenitors (61).”
BackgroundCancer stem cells and human malignant melanoma
Schatton, T., & Frank, M. H. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00427.x · Cited by 210
“However, recent results obtained in the hematopoietic system indicate that CSC can also arise through oncogenic transformation of lineagerestricted progenitor or differentiated cell types (Jamieson et al., 2004; Krivtsov et al., 2006).”
Luis, T. C., Ichii, M., Brugman, M. H., Kincade, P., & Staal, F. J. T. (2012) · Leukemia · doi:10.1038/leu.2011.387 · Cited by 208
“65 In Chronic Myeloid Leukemia caused by the t(9,22) translocation leading to the production of the abnormal BCR–ABL fusion protein, Wnt signaling is activated during blast crises”
Hematopoietic stem cells and their niche
Suda, T., Arai, F., & Hirao, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.006 · Cited by 210
“The Wnt/b-catenin signal, a causative pathway for self-renew, differentiation, and proliferation, is enhanced in the mutated nucleus of granulocyte-macrophage progenitors in the CML patient, due to the higher concentration of the b-catenin and irregularly activated TCF/LEF (T-cell factor/lymphocyte-enhancement factor)…”
BackgroundO'Brien, S., Berman, E., Borghaei, H., DeAngelo, D. J., Devetten, M. P., Devine, S., Erba, H. P., Gotlib, J., Jagasia, M., Moore, J. O., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0065 · Cited by 208
He, J., Nguyen, A. T., & Zhang, Y. (2011) · Blood · doi:10.1182/blood-2010-10-312736 · Cited by 207
Cancer Stem Cells: An Old Idea--A Paradigm Shift
Wicha, M. S., Liu, S., & Dontu, G. (2008) · AACR Education book · doi:10.1158/aacr.edb-can-05-3153 · Cited by 207
Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia
Simon, M., Grandage, V. L., Linch, D. C., & Khwaja, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208431 · Cited by 206
“…recent data showing that the Wnt/b-catenin pathway can promote the selfrenewal of normal stem cells and leukaemic progenitors (Reya et al., 2003; Jamieson et al., 2004), these results suggest that aberrant activation of this pathway may contribute significantly to the malignant phenotype of…”
BackgroundInfluentialCharacterization of a subpopulation of colon cancer cells with stem cell‐like properties
Chu, P., Clanton, D. J., Snipas, T. S., Lee, J., Mitchell, E., Nguyen, M., Hare, E., & Peach, R. J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24061 · Cited by 204
“Activated nuclear b-catenin also has been shown to be important for the self-renewal of chronic myelogenous leukemia (CML) stem cells.(16) Altogether, these observations suggest that b-catenin could be an important link between stem and/or progenitor cells in normal and malignant colon tissue.”
BackgroundIs Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones?
Adams, J. M., & Strasser, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6334 · Cited by 204
“Moreover, because Wnt-1 but not Neu seems to augment mammary stem cell numbers (27), probably by inducing selfrenewal (20), whether other breast cancer models will behave similarly remains to be determined.”
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
Barreyro, L., Will, B., Bartholdy, B., Zhou, L., Todorova, T. I., Stanley, R. F., Ben-Neriah, S., Montagna, C., Parekh, S., Pellagatti, A., et al. (2012) · Blood · doi:10.1182/blood-2012-01-404699 · Cited by 201
Goff, D. J., Recart, A. C., Sadarangani, A., Chun, H.-J., Barrett, C. L., Krajewska, M., Leu, H., Low-Marchelli, J., Ma, W., Shih, A. Y., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.011 · Cited by 201
“, 1990)-expressing hematopoietic stem cells (HSCs) (Jamieson et al., 2004).”
InfluentialBarnes, D. J., Palaiologou, D., Panousopoulou, E., Schultheis, B., Yong, A. S. M., Wong, A., Pattacini, L., Goldman, J. M., & Melo, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0076 · Cited by 200
“(22) reported elevated numbers of BCR-ABL transcripts in the CD34 granulocyte-macrophage progenitor (GMP) subpopulation from blast crisis patients relative to chronic phase patients.”
BackgroundSpisek, R., Kukreja, A., Chen, L.-C., Matthews, P., Mazumder, A., Vesole, D., Jagannath, S., Zebroski, H. A., Simpson, A. J. G., Ritter, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062387 · Cited by 199
Keyes, W. M., Pecoraro, M., Aranda, V., Vernersson-Lindahl, E., Li, W., Vogel, H., Guo, X., Garcia, E. L., Michurina, T. V., Enikolopov, G., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.009 · Cited by 193
Riether, C., Schürch, C. M., Bührer, E. D., Hinterbrandner, M., Huguenin, A.-L., Hoepner, S., Zlobec, I., Pabst, T., Radpour, R., & Ochsenbein, A. F. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20152008 · Cited by 191
“For example, this was shown for the progression of chronic myelogenous leukemia (CML) from chronic to blast phase where the fraction of symmetrically dividing cells increased (Jamieson et al., 2004; Wu et al., 2007; Bajaj et al., 2015).”
BackgroundGetting to the stem of chronic myeloid leukaemia
Savona, M., & Talpaz, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2368 · Cited by 192
“Researchers have postulated myriad cancer stem cell models in which a malignancy is initiated and perpetuated from a cancer stem cell that has HSC-like properties of self-renewal, relative quiescence and resistance to traditional chemotherap”
BackgroundTargeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Borah, A., Raveendran, S., Rochani, A., Maekawa, T., & Kumar, D. S. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.35 · Cited by 192
Acute Myeloid Leukemia Stem Cells
DICK, J. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.001 · Cited by 189
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
Jiang, Q., Crews, L. A., Barrett, C. L., Chun, H.-J., Court, A. C., Isquith, J. M., Zipeto, M. A., Goff, D. J., Minden, M., Sadarangani, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213021110 · Cited by 190
“Our results suggest that ADAR1 p150 up-regulation may contribute to blastic transformation of CML driven by the CD34+ CD38+Lin− progenitor and GMP subpopulations.”
BackgroundInfluentialDevelopmental signaling pathways in cancer stem cells of solid tumors
Karamboulas, C., & Ailles, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.008 · Cited by 190
Du, Y., Jenkins, N. A., & Copeland, N. G. (2005) · Blood · doi:10.1182/blood-2005-03-1113 · Cited by 189
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
Misaghian, N., Ligresti, G., Steelman, L. S., Bertrand, F. E., Bäsecke, J., Libra, M., Nicoletti, F., Stivala, F., Milella, M., Tafuri, A., et al. (2009) · Leukemia · doi:10.1038/leu.2008.246 · Cited by 187
Nieborowska-Skorska, M., Kopinski, P. K., Ray, R., Hoser, G., Ngaba, D., Flis, S., Cramer, K., Reddy, M. M., Koptyra, M., Penserga, T., et al. (2012) · Blood · doi:10.1182/blood-2011-10-385658 · Cited by 177
Dontu, G., & Wicha, M. S. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-2542-5 · Cited by 187
Ysebaert, L., Chicanne, G., Demur, C., De Toni, F., Prade-Houdellier, N., Ruidavets, J.-B., Mansat-De Mas, V, Rigal-Huguet, F., Laurent, G., Payrastre, B., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404239 · Cited by 186
Williams, S. A., Anderson, W. C., Santaguida, M. T., & Dylla, S. J. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.92 · Cited by 186
Targeting the Wnt/β-catenin signaling pathway in human cancers
Yao, H., Ashihara, E., & Maekawa, T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.577418 · Cited by 184
“The Wnt/b-catenin signaling pathway plays a crucial role in the maintenance of CSCs in many cancers, including colon, skin and breast cancer and leukemia [38-42].”
BackgroundInfluentialTarget for cancer therapy: proliferating cells or stem cells
Blagosklonny, M. V. (2006) · Leukemia · doi:10.1038/sj.leu.2404075 · Cited by 184
Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells
Steidl, U., Rosenbauer, F., Verhaak, R. G. W., Gu, X., Ebralidze, A., Otu, H. H., Klippel, S., Steidl, C., Bruns, I., Costa, D. B., et al. (2006) · Nature Genetics · doi:10.1038/ng1898 · Cited by 184
“Human HSCs were isolated from bone marrow as reported previousl”
MethodKikushige, Y., Yoshimoto, G., Miyamoto, T., Iino, T., Mori, Y., Iwasaki, H., Niiro, H., Takenaka, K., Nagafuji, K., Harada, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7358 · Cited by 181
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Minciacchi, V. R., Kumar, R., & Krause, D. S. (2021) · Cells · doi:10.3390/cells10010117 · Cited by 180
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
Schinke, C., Giricz, O., Li, W., Shastri, A., Gordon, S., Barreyro, L., Bhagat, T., Bhattacharyya, S., Ramachandra, N., Bartenstein, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621631 · Cited by 180
“Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs) are heterogeneous malignancies that are thought to arise from a small pool of cancer-initiating cells residing within hematopoietic stem (HSC) and progenitor (HSPC) compartments.(1-9)Despite the use of poly-chemotherapy and the development of newer agen…”
BackgroundHu, Y., Chen, Y., Douglas, L., & Li, S. (2009) · Leukemia · doi:10.1038/leu.2008.262 · Cited by 178
Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and Clinic
Park, C. Y., Tseng, D., & Weissman, I. L. (2009) · Molecular Therapy · doi:10.1038/mt.2008.254 · Cited by 178
Targeted CML therapy: controlling drug resistance, seeking cure
O’Hare, T., Corbin, A. S., & Druker, B. J. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.11.002 · Cited by 178
“Granulocyte-macrophage progenitors from patients with CML in blast crisis were recently reported to exhibit selfrenewal activity in vitro, possibly through activation of bcatenin [51 ].”
BackgroundChronic myeloid leukemia stem cells
Houshmand, M., Simonetti, G., Circosta, P., Gaidano, V., Cignetti, A., Martinelli, G., Saglio, G., & Gale, R. P. (2019) · Leukemia · doi:10.1038/s41375-019-0490-0 · Cited by 177
Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
Avramis, V. I., & Tiwari, P. (2006) · PubMed Central · Cited by 177
Stoyanova, T., Cooper, A. R., Drake, J. M., Liu, X., Armstrong, A. J., Pienta, K. J., Zhang, H., Kohn, D. B., Huang, J., Witte, O. N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320565110 · Cited by 176
Identification and targeting of cancer stem cells
Schatton, T., Frank, N. Y., & Frank, M. H. (2009) · BioEssays · doi:10.1002/bies.200900058 · Cited by 174
“In chronic myeloid leukemia (CML), resistance to the ABL tyrosine kinase inhibitor imatinib was linked to the failure of the chemotherapeutic agent to deplete the LSC compartment, particularly in CML patients in blast crisis.((39,67,68)) Similarly, primary CD34þ CML cells also proved resistant to apoptosis induction b…”
BackgroundJoshua, B., Kaplan, M. J., Doweck, I., Pai, R., Weissman, I. L., Prince, M. E., & Ailles, L. E. (2012) · Head & Neck · doi:10.1002/hed.21699 · Cited by 174
Breast cancer stem cells: Multiple capacities in tumor metastasis
Geng, S.-Q., Alexandrou, A. T., & Li, J. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.036 · Cited by 170
“CSCs at early phases and plays a significant role in the initiation and maintenance of CSCs [44-46].”
BackgroundChen, M. S., Woodward, W. A., Behbod, F., Peddibhotla, S., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03348 · Cited by 170
“Studies in chronic myelogenous leukemia indicate that the elevated levels of nuclear -catenin exist in a minor population of progenitor cells, resulting in their enhanced capacity for self-renewal and increased leukemic potential (Jamieson et al., 2004).”
BackgroundCarter, B. Z., Mak, P. Y., Mu, H., Zhou, H., Mak, D. H., Schober, W., Leverson, J. D., Zhang, B., Bhatia, R., Huang, X., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1180 · Cited by 170
“Furthermore, in these patients, leukemia stem cells can also originate from progenitor cells that acquire self-renewal capacity (10).”
BackgroundLong-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors
Akala, O. O., Park, I.-K., Qian, D., Pihalja, M., Becker, M. W., & Clarke, M. F. (2008) · Nature · doi:10.1038/nature06869 · Cited by 169
c-Jun Induces Mammary Epithelial Cellular Invasion and Breast Cancer Stem Cell Expansion
Jiao, X., Katiyar, S., Willmarth, N. E., Liu, M., Ma, X., Flomenberg, N., Lisanti, M. P., & Pestell, R. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100792 · Cited by 169
Jung, N., Dai, B., Gentles, A. J., Majeti, R., & Feinberg, A. P. (2015) · Nature Communications · doi:10.1038/ncomms9489 · Cited by 168
“Notably, we and others have recently reported that leukaemogenic mutations arise in pre-leukaemic HSC that undergo further clonal evolution to give rise to AML LSC 11–13 , likely in downstream progenitors as has been demonstrated in chronic myeloid leukaemia (CML) 14 .”
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
Román-Gómez, J., Cordeu, L., Agirre, X., Jiménez-Velasco, A., San José-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., & Prosper, F. (2007) · Blood · doi:10.1182/blood-2006-09-047043 · Cited by 168
RetractedPathania, R., Ramachandran, S., Mariappan, G., Thakur, P., Shi, H., Choi, J.-H., Manicassamy, S., Kolhe, R., Prasad, P. D., Sharma, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2249 · Cited by 165
“For example, a mutation that enhances β-catenin signaling in granulocytemacrophage progenitor cells causes a blast crisis in patients with chronic myeloid leukemia (20).”
Background
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.